This week we’ve highlighted the RSV vaccine race, J.P. Morgan’s private equity life sciences investment, a new product promoting decentralized oncology trials, the shocking expected cost of gene therapies, and Moderna’s revised earnings forecast amid falling COVID-19 cases. Each week we highlight five ... READ MORE >
Life Sciences
The life sciences sector comprises some of the middle market’s fastest-growing companies. Whether developing life-saving new drugs or robotic components for surgery, this vibrant sector is a hotbed of innovation.
5 things to know in life sciences: Week of Oct. 17
This week we’ve highlighted the White House’s strategy to address future pandemics, President Biden’s executive order on lowering prescription drug costs, the availability and reduced pricing of hearing aids, and the Food and Drug Administration’s updated authorization for Moderna and Pfizer-BioNTech ... READ MORE >
5 things to know in life sciences: Week of Oct. 10
This week, we look at collaboration arrangements in the areas of artificial intelligence and cancer treatment. We also highlight a retina scan that can predict heart disease and a digital treatment of lazy eye. Finally, we look at a pre-clinical biotech company that has raised $386 million in less than ... READ MORE >
5 things to know in life sciences: Week of Oct. 3
This week we look at how doctors are using virtual reality to help children manage their fear while in the hospital. We also highlight a new cloud analytics tool for wearables, drug pipeline planning and new research into the virus that causes monkeypox. Finally, we track the path from fossilized DNA to a ... READ MORE >
5 things to know in life sciences: Week of Sept. 26
This week we look at how energy insecurity and supply chain disruptions are affecting generic drug manufacturers in Europe. We also highlight new treatments for amyotrophic lateral sclerosis (ALS) and Alzheimer’s, as well as the challenges of starting vaccine trials in the midst of an Ebola outbreak. ... READ MORE >
5 things to know in life sciences: Week of Sept. 19
This week, we look at another drug breaking the record for most expensive in the world, a complicated labor market with layoffs at many large pharmaceutical companies and expansions at others, and plans to build a quantum computer for life sciences research. We also look at GSK requiring various ... READ MORE >
5 things to know in life sciences: Week of Sept. 12
This week, we look at a new executive order encouraging biomanufacturing, a rare company going public through a special purpose acquisition company and what an executive can do when a trial is placed on a clinical hold. We also look at how progress in curing hepatitis C remains slow despite revolutionary ... READ MORE >
5 things to know in life sciences: Week of Aug. 29
This week we look at a cancer immunotherapy breakthrough that could strengthen chimeric antigen receptor T cells in their fight against liquid or solid tumors. We also highlight an unexpected special purpose acquisition company transaction revival, continued efforts to improve clinical trial diversity, ... READ MORE >
5 things to know in life sciences: Week of Aug. 22
This week we look at the challenges of scaling up monkeypox vaccine production to meet demand as the outbreak continues to grow globally. We also examine the large number of COVID-19 diagnostics, using real-world data to study pregnancy, and the promise of new stem cell studies coming from Japan. Finally, ... READ MORE >
5 things to know in life sciences: Week of Aug. 15
This week, we look at the challenges of scaling up monkeypox vaccine production to meet demand as the outbreak continues to grow globally. We also look at a major spin-off of a clinical research organization, over-the-counter hearing aid sales, and one bright spot in the capital markets. Finally, we look ... READ MORE >